Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus (Q51556166)

7 April 2018

title

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus (English)

1 reference

7 April 2018

0 references

1 reference

Nolan JJ

1 reference

7 April 2018

Jones NP

series ordinal

1 reference

7 April 2018

Patwardhan R

series ordinal

1 reference

7 April 2018

Deacon LF

series ordinal

1 reference

7 April 2018

publication date

1 April 2000

1 reference

7 April 2018

published in

Diabetic Medicine

1 reference

7 April 2018

volume

1 reference

7 April 2018

issue

1 reference

7 April 2018

page(s)

287-294

1 reference

7 April 2018

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

21 January 2018

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00269.X

10.1046/J.1464-5491.2000.00269.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018